SNSE: Sensei Biotherapeutics, Inc. Stock

by  •  • Comments Off on SNSE: Sensei Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.57
Enterprise Value ($M) 12.56
Book Value ($M) 71.00
Book Value / Share 2.83
Price / Book 0.36
NCAV ($M) 57.77
NCAV / Share 2.30
Price / NCAV 0.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 11.92
Current Ratio 11.92

Balance Sheet (mrq) ($M)
Current Assets 67.25
Assets 74.37
Liabilities 9.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -37.06
Net Income -34.10

Cash Flow Statement (mra) ($M)
Cash From Operations -32.02
Cash from Investing 38.41
Cash from Financing -11.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13D/A Newtyn Management, LLC 4.95 -14.72
08-04 13G/A Cambrian BioPharma Inc 14.60 -30.23
06-02 13D/A Apeiron Investment Group Ltd. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 928 430 215.81
2024-04-25 3,751 11,476 32.69
2024-04-24 6,766 3,791 178.48
2024-04-23 8,611 13,783 62.48

(click for more detail)

Similar Companies
SKYE – Skye Bioscience, Inc. SLGL – Sol-Gel Technologies Ltd.
SMMT – Summit Therapeutics Inc. SPRY – ARS Pharmaceuticals, Inc.
STRO – Sutro Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io